Open access
Open access
Powered by Google Translator Translator

All Posts

Ten myths about albumin.

7 Mar, 2022 | 00:44h | UTC

Ten myths about albumin – Intensive Care Medicine (free for a limited period)

 

Commentary on Twitter

 

Review articles: Cutaneous manifestations of SARS-CoV-2 infection.

7 Mar, 2022 | 00:38h | UTC

Cutaneous Manifestations of SARS-CoV-2 Infection – American Journal of Clinical Dermatology

Common skin signs of COVID-19 in adults: An update – Cleveland Clinic Journal of Medicine

 

The Lancet Series: Ageing with HIV.

7 Mar, 2022 | 00:35h | UTC

Homepage: Ageing with HIV

Editorials:

Ageing with HIV

Time to tackle late diagnosis

Series:

Delayed presentation of HIV among older individuals: a growing problem

How health systems can adapt to a population ageing with HIV and comorbid disease

Biological ageing with HIV infection: evaluating the geroscience hypothesis

Intersectionality of stigmas and health-related quality of life in people ageing with HIV in China, Europe, and Latin America

 

New research finds breast cancer overdiagnosis not as common as previously thought.

7 Mar, 2022 | 00:36h | UTC

Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort – Annals of Internal Medicine (link to abstract – $ for full-text)

How often is breast cancer overdiagnosed? New research finds true cases far outweigh false alarms – STAT

Breast cancer overdiagnosis may not happen as frequently as previously thought – ACP Internist

 

RCT: Efficacy and safety of switching to the 2-drug regimen Dolutegravir/Lamivudine vs. continuing a 3- or 4-Drug regimen for maintaining virologic suppression in adults living with HIV-1.

7 Mar, 2022 | 00:32h | UTC

Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With HIV-1: Week 48 Results From the Phase 3, Non-inferiority SALSA Randomized Trial – Clinical Infectious Diseases

 

Over 1 billion people projected to live with obesity by 2030, warns new World Obesity Atlas.

7 Mar, 2022 | 00:12h | UTC

Commentary: Over 1 Billion People Projected to Live with Obesity by 2030, Warns New World Obesity Atlas – Health Policy Watch

Report: Obesity Atlas 2022 – Global Obesity Observatory

 

WHO global standard for safe listening venues and events.

7 Mar, 2022 | 00:17h | UTC

WHO global standard for safe listening venues and events – World Health Organization

Q&A: Deafness and hearing loss: Safe listening – World Health Organization

Commentaries:

WHO Releases New Noise Standard for Public Venues to Tackle Hearing Loss – Health Polity Watch

Obesity rates likely to double by 2030 with highest rises in lower-income countries – The Guardian

 

Commentary on Twitter (thread – click for more)

 

WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections.

7 Mar, 2022 | 00:09h | UTC

WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections – World Journal of Emergency Surgery

 

WSES guidelines on blunt and penetrating bowel injury: diagnosis, investigations, and treatment.

7 Mar, 2022 | 00:11h | UTC

WSES guidelines on blunt and penetrating bowel injury: diagnosis, investigations, and treatment – World Journal of Emergency Surgery

 

M-A: Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma.

7 Mar, 2022 | 00:07h | UTC

Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis – The Lancet Oncology

 

Commentary from the author on Twitter (thread – click for more)

 

Multiparametric ultrasound vs. multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study.

7 Mar, 2022 | 00:04h | UTC

Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study – The Lancet Oncology (link to abstract – $ for full-text)

News Release: Ultrasound scan can diagnose prostate cancer – Imperial College London

 

Commentary on Twitter

 

Lab study tested an extensive range of possibly effective drug combinations in breast, colon, and pancreatic cancer cells.

7 Mar, 2022 | 00:03h | UTC

Effective drug combinations in breast, colon and pancreatic cancer cells – Nature

Commentaries:

New drug combinations found for resistant cancers – Wellcome Trust Sanger Institute

Study predicts treatment combinations for resistant cancers – Frontline Genomics

 

Arterial blood gas analysis: as safe as we think? A multicentre historical cohort study.

7 Mar, 2022 | 00:00h | UTC

Arterial blood gas analysis: as safe as we think? A multicentre historical cohort study – ERJ Open

 

RCT: Supplementing milk with enteral recombinant human insulin in preterm infants is safe and results in earlier achievement of full enteral feeding.

6 Mar, 2022 | 23:58h | UTC

Efficacy and Safety of Enteral Recombinant Human Insulin in Preterm Infants: A Randomized Clinical Trial – JAMA Pediatrics (link to abstract – $ for full-text)

Commentary: Enteral insulin reduces the duration of feeding intolerance in preterm infants – MedPage Today (free registration required)

 

Commentary on Twitter

 

Hepatorenal Syndrome Type 1: From diagnosis ascertainment to goal-oriented pharmacologic therapy.

6 Mar, 2022 | 23:47h | UTC

Hepatorenal Syndrome Type 1: From Diagnosis Ascertainment to Goal-Oriented Pharmacologic Therapy – Kidney360

 

Viewpoint | Looking back on the history of patient safety: an opportunity to reflect and ponder future challenges.

6 Mar, 2022 | 23:51h | UTC

Looking back on the history of patient safety: an opportunity to reflect and ponder future challenges – BMJ Quality & Safety

 

Systematic Review: Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding.

6 Mar, 2022 | 23:41h | UTC

Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding – Cochrane Library

Commentary: Pre-Endoscopic Proton Pump Inhibitor Use May Decrease Risk for Endoscopic Hemostatic Treatment – Gastroenterology Advisor

 

Brief Review: Contemporary inguinal hernia management.

6 Mar, 2022 | 23:46h | UTC

Contemporary inguinal hernia management – British Journal of Surgery (free for a limited period)

 

Commentary on Twitter

 

Distribution of delirium motor subtypes in the intensive care unit: a systematic scoping review.

6 Mar, 2022 | 23:38h | UTC

Distribution of delirium motor subtypes in the intensive care unit: a systematic scoping review – Critical Care

 

Systematic Review: Routine vaginal examinations compared to other methods for assessing progress of labor to improve outcomes for women and babies at term.

6 Mar, 2022 | 23:44h | UTC

Routine vaginal examinations compared to other methods for assessing progress of labour to improve outcomes for women and babies at term – Cochrane Library

Summary: Routine vaginal examinations in labour – Cochrane Library

 

RCT: Preliminary trial suggests neostigmine may improve intra-abdominal hypertension and increase defecation in patients with acute pancreatitis.

6 Mar, 2022 | 23:39h | UTC

Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis – Critical Care

 

M-A: Bariatric surgery and cardiovascular disease.

6 Mar, 2022 | 23:34h | UTC

Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis – European Heart Journal

 

Opinion: Standing on a vibrating platform could deliver some of the same benefits as exercise.

6 Mar, 2022 | 23:36h | UTC

Standing on a vibrating platform could deliver some of the same benefits as exercise – The Conversation

 

Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials.

6 Mar, 2022 | 23:32h | UTC

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials – Journal of Clinical Oncology

Commentaries:

Women at higher risk of severe adverse events from cancer therapy – eCancer

Women Face Higher Risk for Severe AEs From Cancer Therapy – HealthDay

 

Commentary on Twitter

 

[Preprint] RECOVERY trial shows Baricitinib reduces deaths in patients hospitalized with COVID-19.

4 Mar, 2022 | 10:09h | UTC

News Release: RECOVERY trial shows Baricitinib reduces deaths in patients hospitalised with COVID-19 – University of Oxford

Original study: Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis – medRxiv

Commentaries:

Arthritis drug reduces mortality in severe COVID-19, huge clinical trial finds – Science

Covid-19: Anti-inflammatory treatment baricitinib reduces deaths in patients admitted to hospital, finds trial – The BMJ

Another life-saving Covid drug identified – BBC

Related:

WHO recommends two new drugs (Baricitinib and Sotrovimab) to treat COVID-19.

RCT: Baricitinib reduced mortality in hospitalized adults with COVID-19.

Randomized trial: Baricitinib plus remdesivir reduce recovery time in patients with COVID-19

 

Commentary from the author on Twitter (thread – click for more)

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.